Each IRB must follow the written procedures set forth in the assurance and, except in the case of expedited review, review of the research must occur at meetings where a majority of the IRB members are present, including at least one member with a background in a field other than science; approval requires a majority of those present at the meeting.
i. Review of Research
IRBs may approve, disapprove, or require modifications to research proposals. The IRB must provide written documentation of its decision to the institution; if the IRB disapproves the research proposal, the IRB must include in writing the reasons for the disapproval, and the institution must be given a chance to respond.
IRBs must require information to be provided to subjects to facilitate informed consent as defined in the Common Rule; IRBs may require additional information to be provided to research subjects if the information would contribute to the protection of their rights and welfare. An IRB may require documentation of compliance with the informed consent policy or waive the documentation requirement.
The IRB must review the research on a continuing basis at least once a year, and riskier research should be reviewed on more than an annual basis; the IRB or a third party may observe the consent process and the research.
ii. Criteria for Approval
Research may only be approved by IRB if all of the following conditions are met:
-
Risks to the subjects are minimized, and if possible, risks should be minimized by using procedures that are already being performed on the human subjects for purposes of diagnosis or treatment;
-
Risks to the subjects are considered reasonable in light of the potential benefits, both to the subject and to society with regard to the knowledge that may be gained from the research;
-
The subjects are selected for the research in an “equitable” manner, in light of the research’s purpose, the research’s setting, and the involvement of vulnerable populations such as children, pregnant women, prisoners, and individuals who are disadvantaged economically or educationally;
-
Informed consent is secured from each subject, or the subject’s representative who is legally authorized to give informed consent;
-
If appropriate, the research proposal includes provisions regarding monitoring of the collection of data to guarantee the subjects’ safety;
-
If appropriate, the research proposal includes provisions regarding data confidentiality to protect the subjects’ privacy.
-
Additional precautions should be taken if the research subjects belong to a vulnerable population.
iii. Expedited Review
Expedited IRB review is available for:
-
Research that appears on a list published by the Secretary in the Federal Register, which, in consultation with other agencies, outlines categories of research that may take advantage of expedited review, and the research does not create more than a minimal risk; and/or
-
Research that has been approved in the last year, with minor changes
In an expedited review situation, an IRB chairperson or an experienced IRB reviewer may act on behalf of the IRB to review the research, and may take any IRB action other than to disapprove of the research; research disapproval may only occur through the non-expedited review procedure.
All members of an IRB must be kept informed about research that has been approved under expedited review.
The head of a department or agency may restrict the use of expedited review procedures.
iv. Suspension or Termination of IRB Approval
An IRB may suspend or terminate approval of research if the research is not being conducted in a manner consistent with the requirements set out by the IRB, or if the research has the potential to produce unexpected and serious harm to the subjects. An IRB must include a statement explaining the reasons for suspension or termination of approval, and the suspension or termination must be reported to the investigator, the institution officials, and the head of the department or agency.